ID: ALA1765957

Max Phase: Preclinical

Molecular Formula: C28H35N

Molecular Weight: 385.60

Molecule Type: Small molecule

Associated Items:

Representations

Canonical SMILES:  C=C(c1ccccc1)[C@@]12CN(C)C[C@@H]1CC(CCCCCC)=C2c1ccccc1

Standard InChI:  InChI=1S/C28H35N/c1-4-5-6-9-18-25-19-26-20-29(3)21-28(26,22(2)23-14-10-7-11-15-23)27(25)24-16-12-8-13-17-24/h7-8,10-17,26H,2,4-6,9,18-21H2,1,3H3/t26-,28-/m0/s1

Standard InChI Key:  RVIUUYICERBOIG-XCZPVHLTSA-N

Associated Targets(Human)

Orphan nuclear receptor LRH-1 736 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Steroidogenic factor 1 399 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Associated Targets(non-human)

Steroidogenic factor 1 16 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 385.60Molecular Weight (Monoisotopic): 385.2770AlogP: 7.08#Rotatable Bonds: 8
Polar Surface Area: 3.24Molecular Species: BASEHBA: 1HBD: 0
#RO5 Violations: 1HBA (Lipinski): 1HBD (Lipinski): 0#RO5 Violations (Lipinski): 1
CX Acidic pKa: CX Basic pKa: 9.77CX LogP: 6.96CX LogD: 4.62
Aromatic Rings: 2Heavy Atoms: 29QED Weighted: 0.44Np Likeness Score: 0.52

References

1. Whitby RJ, Stec J, Blind RD, Dixon S, Leesnitzer LM, Orband-Miller LA, Williams SP, Willson TM, Xu R, Zuercher WJ, Cai F, Ingraham HA..  (2011)  Small molecule agonists of the orphan nuclear receptors steroidogenic factor-1 (SF-1, NR5A1) and liver receptor homologue-1 (LRH-1, NR5A2).,  54  (7): [PMID:21391689] [10.1021/jm1014296]

Source